Experiencia de 20 años en tratamiento conservador del cáncer de laringe estadio III y IV operable del equipo multidisciplinario del Instituto Angel H Roffo / 20 Years experience with organ preservation in resecable stage III and IV laryngeal cancer by a multidisciplinary of them the

ABSTRACT

The classic treatment of the laryngeal resectable stage III and IV epi-dermoid cancer is surgery followed by adjuvant radiotherapy. Only on scarce occasions these patients can accede to organ preservation conserving correct phonetics and deglution with absence of aspiration. In most of the occasions the procedure of choice is total laryngectomy with or without cervical emptying if it is necessary. Since the end of the '80s. we have developed strategies for organ preservation of the tumors of the head and neck. Despite the implementation of the neoadjuvant chemotherapy and the later use of chemoradiotherapy simultaneously or the introduction of monoclonal antibodies anti EGFR (anti epidemic growth receptor factor), the rate of survival of the tumors in resectabale stage III and IV epidermoid carcinoma remains stable. The authors present their experience with the management of these patients, considering that the two main objectives for the development of new strategies for the treatment of laryngeal cancer are to raise the rate of survival, and the rate of larynx preservation. La rynx preservation using induction chemotherapy plus radiation therapy, and preservation in cases of advance laryngeal cancer treated with platinum, are also considered. Preservation using neoadjuvant chemotherapy is also detailed. The authors presents their experience with the management of these patients.